Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!
Evaluation of hemodynamic properties of cerebral venous drainage in patients with multiple sclerosis: a case-control study.
Human Wharton?s jelly-derived stem cells display immunomodulatory properties and transiently improve rat experimental autoimmune encephalomyelitis.
Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme CYP24A1 in multiple sclerosis.
A Model of Population and Subject (MOPS) Intensities with Application to Multiple Sclerosis Lesion Segmentation.
Treatment Adherence and Transitioning Youth in Pediatric Multiple Sclerosis.
Mesenchymal Stem Cells and Induced Pluripotent Stem Cells as Therapies for Multiple Sclerosis.
Impact of natalizumab treatment on fatigue, mood, and aspects of cognition in relapsing-remitting multiple sclerosis.
Predicting degree of myelination based on diffusion tensor imagining of canines with mucopolysaccharidosis type I.
Evaluation of locomotor function and microscopic structure of the spinal cord in a mouse model of experimental autoimmune encephalomyelitis following treatment with syngeneic mesenchymal stem cells.
Managing Disability in Progressive Multiple Sclerosis.
Crossreactivity of a human autoimmune TCR is dominated by a single TCR loop.
Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
Resolvin d1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses.
Subclinical Optic Neuritis in Neuromyelitis Optica.
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome.
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab.
Therapeutic compliance of first line disease-modifying therapies in patients with multiple sclerosis. COMPLIANCE Study.
Adaptive voxel, texture and temporal conditional random fields for detection of Gad-enhancing multiple sclerosis lesions in brain MRI.
A clinical and radiological profile of neuromyelitis optica and spectrum disorders in an Indian cohort.
Angiopoietin-1 ameliorates inflammation-induced vascular leakage and improves functional impairment in a rat model of acute experimental autoimmune encephalomyelitis.
Adult-onset vanishing white matter disease as differential diagnosis of primary progressive multiple sclerosis: A case report.
A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications.
Changes in Gross Grasp Strength and Fine Motor Skills in Adolescents with Pediatric Multiple Sclerosis.
Pages
« first
‹ previous
…
367
368
369
370
371
372
373
374
375
…
next ›
last »